Collaboration
The development and evaluation of new applications of CBT-E
This research programme is led by Dr Riccardo Dalle Grave. It is based in Verona (Italy) and a clinic nearby (Villa Garda) at Lake Garda. It is CBT-E centred and focuses on its evaluation and use in different settings and with different populations. The settings have included inpatient and day patient settings, and the studies have included both adults and young people.
Further Reading
Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Palmer RL, Dalle Grave R. Enhanced cognitive behaviour therapy for adults with anorexia nervosa: A UK-Italy study. Behaviour Research and Therapy 2013; 51: 2-8.
Dalle Grave R, Callugi S, Doll HA, Fairburn CG. Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: An alternative to family therapy? Behaviour Research and Therapy 2013; 51: 9-12.
Dalle Grave R, Calugi S, Conti M, Doll HA, Fairburn CG. Inpatient cognitive behaviour therapy for anorexia nervosa: A randomized controlled trial. Psychotherapy and Psychosomatics 2013; 82: 390-398.
Dalle Grave R, Calugi S, El Ghoch M, Conti M, Fairburn CG. Inpatient cognitive behavior therapy for adolescents with anorexia nervosa: Immediate and longer-term effects. Frontiers in Psychiatry 2014; 5: 14, 1-7.
Calugi S, Dalle Grave R, Sartirana M, Fairburn CG. Time to restore body weight in adults and adolescents receiving cognitive behavior therapy for anorexia nervosa. Journal of Eating Disorders 2015; 3: 21.
A trial of enhanced CBT (CBT-E) following inpatient treatment
This new research programme is based at Toronto General Hospital and it is led by the Director of the Eating Disorder Program, Professor Marion Olmsted. The goal is to compare conventional CBT with CBT-E in the post-hospitalisation treatment of patients with severe eating disorders. Professors Fairburn and Cooper are collaborators. Professor Cooper will be providing the study therapists with training and supervision in CBT-E. The hope is that CBT-E will improve the outcome that is typically seen in this patient group.